Correlation Between Aion Therapeutic and AusCann Group

Can any of the company-specific risk be diversified away by investing in both Aion Therapeutic and AusCann Group at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aion Therapeutic and AusCann Group into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Aion Therapeutic and AusCann Group Holdings, you can compare the effects of market volatilities on Aion Therapeutic and AusCann Group and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aion Therapeutic with a short position of AusCann Group. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aion Therapeutic and AusCann Group.

Diversification Opportunities for Aion Therapeutic and AusCann Group

0.09

Correlation Coefficient

Aion Therapeutic  AusCann Group

Significant diversification

The 3 months correlation between Aion and AusCann is 0.09. Overlapping area represents the amount of risk that can be diversified away by holding Aion Therapeutic and AusCann Group Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AusCann Group Holdings and Aion Therapeutic is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aion Therapeutic are associated (or correlated) with AusCann Group. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AusCann Group Holdings has no effect on the direction of Aion Therapeutic i.e., Aion Therapeutic and AusCann Group go up and down completely randomly.

Pair Corralation between Aion Therapeutic and AusCann Group

Assuming the 90 days horizon Aion Therapeutic is expected to generate 3.6 times less return on investment than AusCann Group. But when comparing it to its historical volatility, Aion Therapeutic is 2.33 times less risky than AusCann Group. It trades about 0.11 of its potential returns per unit of risk. AusCann Group Holdings is currently generating about 0.16 of returns per unit of risk over similar time horizon. If you would invest  0.30  in AusCann Group Holdings on September 14, 2024 and sell it today you would earn a total of  0.08  from holding AusCann Group Holdings or generate 26.67% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	86.46%
Values	Daily Returns

Aion Therapeutic  vs.  AusCann Group Holdings

Aion Therapeutic

Risk-Adjusted Performance

12 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Aion Therapeutic are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile fundamental indicators, Aion Therapeutic reported solid returns over the last few months and may actually be approaching a breakup point.

AusCann Group Holdings

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days AusCann Group Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, AusCann Group is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.

Pair Trading with Aion Therapeutic and AusCann Group

The main advantage of trading using opposite Aion Therapeutic and AusCann Group positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aion Therapeutic position performs unexpectedly, AusCann Group can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AusCann Group will offset losses from the drop in AusCann Group's long position.

The idea behind Aion Therapeutic and AusCann Group Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.